List of Excipients in API dextroamphetamine
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing dextroamphetamine
Excipients in ANDA-approved (generic) drugs containing dextroamphetamine
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| Tris Pharma Inc | dextroamphetamine | 27808-085 | ANHYDROUS CITRIC ACID |
| Tris Pharma Inc | dextroamphetamine | 27808-085 | BENZOIC ACID |
| Tris Pharma Inc | dextroamphetamine | 27808-085 | SACCHARIN |
| Tris Pharma Inc | dextroamphetamine | 27808-085 | SODIUM CITRATE |
| Tris Pharma Inc | dextroamphetamine | 27808-085 | SORBITOL |
| Tris Pharma Inc | dextroamphetamine | 27808-085 | WATER |
| Bryant Ranch Prepack | dextroamphetamine | 72162-2043 | ANHYDROUS CITRIC ACID |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for dextroamphetamine
Excipient focus: ALCOHOL
dextroamphetamine drug variants containing ALCOHOL
dextroamphetamine drug variants not containing ALCOHOL
Excipient focus: ALUMINUM OXIDE
dextroamphetamine drug variants containing ALUMINUM OXIDE
dextroamphetamine drug variants not containing ALUMINUM OXIDE
Excipient focus: AMMONIA
dextroamphetamine drug variants containing AMMONIA
dextroamphetamine drug variants not containing AMMONIA
Excipient focus: AMMONIO METHACRYLATE COPOLYMER TYPE A
dextroamphetamine drug variants containing AMMONIO METHACRYLATE COPOLYMER TYPE A
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, amphetamine sulfate | 0228-3062 |
| >Company | >Ingredient | >NDC |
dextroamphetamine drug variants not containing AMMONIO METHACRYLATE COPOLYMER TYPE A
Excipient focus: AMMONIO METHACRYLATE COPOLYMER TYPE B
dextroamphetamine drug variants containing AMMONIO METHACRYLATE COPOLYMER TYPE B
dextroamphetamine drug variants not containing AMMONIO METHACRYLATE COPOLYMER TYPE B
Excipient focus: ANHYDROUS CITRIC ACID
dextroamphetamine drug variants containing ANHYDROUS CITRIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Tris Pharma Inc | dextroamphetamine | 27808-085 |
| Bryant Ranch Prepack | dextroamphetamine | 72162-2043 |
| INDEPENDENCE PHARMACEUTICALS LLC | dextroamphetamine sulfate | 21724-701 |
| Mikart LLC | dextroamphetamine sulfate | 46672-646 |
| Prasco Laboratories | dextroamphetamine sulfate | 66993-359 |
| >Company | >Ingredient | >NDC |
dextroamphetamine drug variants not containing ANHYDROUS CITRIC ACID
Excipient focus: BENZOIC ACID
dextroamphetamine drug variants containing BENZOIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| INDEPENDENCE PHARMACEUTICALS LLC | dextroamphetamine sulfate | 21724-701 |
| Tris Pharma Inc | dextroamphetamine | 27808-085 |
| Mikart LLC | dextroamphetamine sulfate | 46672-646 |
| Prasco Laboratories | dextroamphetamine sulfate | 66993-359 |
| Bryant Ranch Prepack | dextroamphetamine | 72162-2043 |
| >Company | >Ingredient | >NDC |
dextroamphetamine drug variants not containing BENZOIC ACID
Excipient focus: BUTYL ALCOHOL
dextroamphetamine drug variants containing BUTYL ALCOHOL
dextroamphetamine drug variants not containing BUTYL ALCOHOL
Excipient focus: CALCIUM PHOSPHATE
dextroamphetamine drug variants containing CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Tris Pharma Inc | dextroamphetamine sulfate | 27808-089 |
| >Company | >Ingredient | >NDC |
dextroamphetamine drug variants not containing CALCIUM PHOSPHATE
Excipient focus: CALCIUM SULFATE
dextroamphetamine drug variants containing CALCIUM SULFATE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals USA Inc | dextroamphetamine sulfate | 0555-0952 |
| Zydus Pharmaceuticals (USA) Inc | dextroamphetamine sulfate | 68382-941 |
| >Company | >Ingredient | >NDC |
dextroamphetamine drug variants not containing CALCIUM SULFATE
Excipient focus: CAPRYLIC/CAPRIC MONO/DI-GLYCERIDES
dextroamphetamine drug variants containing CAPRYLIC/CAPRIC MONO/DI-GLYCERIDES
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals (USA) Inc | dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate | 70710-1184 |
| >Company | >Ingredient | >NDC |
dextroamphetamine drug variants not containing CAPRYLIC/CAPRIC MONO/DI-GLYCERIDES
Excipient focus: CARBOXYMETHYLCELLULOSE
dextroamphetamine drug variants containing CARBOXYMETHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Teva Pharmaceuticals Inc | dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate | 0480-3683 |
| >Company | >Ingredient | >NDC |
dextroamphetamine drug variants not containing CARBOXYMETHYLCELLULOSE
Excipient focus: CELLULOSE, MICROCRYSTALLINE
dextroamphetamine drug variants containing CELLULOSE, MICROCRYSTALLINE
dextroamphetamine drug variants not containing CELLULOSE, MICROCRYSTALLINE
Excipient focus: CETYL ALCOHOL
dextroamphetamine drug variants containing CETYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals of New York LLC | dextroamphetamine sulfate | 0115-1702 |
| Amneal Pharmaceuticals of New York LLC | dextroamphetamine sulfate | 0115-9927 |
| Amneal Pharmaceuticals LLC | dextroamphetamine sulfate | 64896-673 |
| >Company | >Ingredient | >NDC |
dextroamphetamine drug variants not containing CETYL ALCOHOL
Excipient focus: COLLOIDAL SILICON DIOXIDE
dextroamphetamine drug variants containing COLLOIDAL SILICON DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine suflate | 16590-901 |
| >Company | >Ingredient | >NDC |
dextroamphetamine drug variants not containing COLLOIDAL SILICON DIOXIDE
Excipient focus: CORN STARCH 3-E-DODECENYL SUCCINIC ANHYDRIDE MODIFIED
dextroamphetamine drug variants containing CORN STARCH 3-E-DODECENYL SUCCINIC ANHYDRIDE MODIFIED
| Company | Ingredient | NDC |
|---|---|---|
| SpecGx LLC | dextroamphetamine sulfate | 0406-8960 |
| >Company | >Ingredient | >NDC |
dextroamphetamine drug variants not containing CORN STARCH 3-E-DODECENYL SUCCINIC ANHYDRIDE MODIFIED
Excipient focus: CROSPOVIDONE
dextroamphetamine drug variants containing CROSPOVIDONE
dextroamphetamine drug variants not containing CROSPOVIDONE
Excipient focus: D&C RED NO. 27
dextroamphetamine drug variants containing D&C RED NO. 27
dextroamphetamine drug variants not containing D&C RED NO. 27
Excipient focus: D&C RED NO. 28
dextroamphetamine drug variants containing D&C RED NO. 28
dextroamphetamine drug variants not containing D&C RED NO. 28
Excipient focus: D&C RED NO. 33
dextroamphetamine drug variants containing D&C RED NO. 33
dextroamphetamine drug variants not containing D&C RED NO. 33
Excipient focus: D&C YELLOW NO. 10
dextroamphetamine drug variants containing D&C YELLOW NO. 10
dextroamphetamine drug variants not containing D&C YELLOW NO. 10
Excipient focus: D&C YELLOW NO. 10 ALUMINUM LAKE
dextroamphetamine drug variants containing D&C YELLOW NO. 10 ALUMINUM LAKE
dextroamphetamine drug variants not containing D&C YELLOW NO. 10 ALUMINUM LAKE
Excipient focus: DEHYDRATED ALCOHOL
dextroamphetamine drug variants containing DEHYDRATED ALCOHOL
dextroamphetamine drug variants not containing DEHYDRATED ALCOHOL
Excipient focus: DIBUTYL SEBACATE
dextroamphetamine drug variants containing DIBUTYL SEBACATE
dextroamphetamine drug variants not containing DIBUTYL SEBACATE
Excipient focus: ETHYLCELLULOSE
dextroamphetamine drug variants containing ETHYLCELLULOSE
dextroamphetamine drug variants not containing ETHYLCELLULOSE
Excipient focus: ETHYLCELLULOSES
dextroamphetamine drug variants containing ETHYLCELLULOSES
| Company | Ingredient | NDC |
|---|---|---|
| Mayne Pharma Inc | dextroamphetamine sulfate | 51862-344 |
| Physicians Total Care Inc | dextroamphetamine sulfate | 54868-5479 |
| Amneal Pharmaceuticals LLC | dextroamphetamine sulfate | 64896-673 |
| >Company | >Ingredient | >NDC |
dextroamphetamine drug variants not containing ETHYLCELLULOSES
Excipient focus: FD&C BLUE NO. 1
dextroamphetamine drug variants containing FD&C BLUE NO. 1
dextroamphetamine drug variants not containing FD&C BLUE NO. 1
Excipient focus: FD&C BLUE NO. 1 ALUMINUM LAKE
dextroamphetamine drug variants containing FD&C BLUE NO. 1 ALUMINUM LAKE
dextroamphetamine drug variants not containing FD&C BLUE NO. 1 ALUMINUM LAKE
Excipient focus: FD&C BLUE NO. 1--ALUMINUM LAKE
dextroamphetamine drug variants containing FD&C BLUE NO. 1--ALUMINUM LAKE
dextroamphetamine drug variants not containing FD&C BLUE NO. 1--ALUMINUM LAKE
Excipient focus: FD&C BLUE NO. 2
dextroamphetamine drug variants containing FD&C BLUE NO. 2
dextroamphetamine drug variants not containing FD&C BLUE NO. 2
Excipient focus: FD&C BLUE NO. 2--ALUMINUM LAKE
dextroamphetamine drug variants containing FD&C BLUE NO. 2--ALUMINUM LAKE
dextroamphetamine drug variants not containing FD&C BLUE NO. 2--ALUMINUM LAKE
Excipient focus: FD&C GREEN NO. 3
dextroamphetamine drug variants containing FD&C GREEN NO. 3
dextroamphetamine drug variants not containing FD&C GREEN NO. 3
Excipient focus: FD&C RED NO. 3
dextroamphetamine drug variants containing FD&C RED NO. 3
dextroamphetamine drug variants not containing FD&C RED NO. 3
Excipient focus: FD&C RED NO. 40
dextroamphetamine drug variants containing FD&C RED NO. 40
dextroamphetamine drug variants not containing FD&C RED NO. 40
Excipient focus: FD&C YELLOW NO. 6
dextroamphetamine drug variants containing FD&C YELLOW NO. 6
dextroamphetamine drug variants not containing FD&C YELLOW NO. 6
Excipient focus: FERRIC OXIDE RED
dextroamphetamine drug variants containing FERRIC OXIDE RED
dextroamphetamine drug variants not containing FERRIC OXIDE RED
Excipient focus: FERRIC OXIDE YELLOW
dextroamphetamine drug variants containing FERRIC OXIDE YELLOW
dextroamphetamine drug variants not containing FERRIC OXIDE YELLOW
Excipient focus: FERROSOFERRIC OXIDE
dextroamphetamine drug variants containing FERROSOFERRIC OXIDE
dextroamphetamine drug variants not containing FERROSOFERRIC OXIDE
Excipient focus: FERROUS OXIDE
dextroamphetamine drug variants containing FERROUS OXIDE
dextroamphetamine drug variants not containing FERROUS OXIDE
Excipient focus: GELATIN
dextroamphetamine drug variants containing GELATIN
dextroamphetamine drug variants not containing GELATIN
Excipient focus: GLYCERYL MONOSTEARATE
dextroamphetamine drug variants containing GLYCERYL MONOSTEARATE
dextroamphetamine drug variants not containing GLYCERYL MONOSTEARATE
Excipient focus: HYDROXYPROPYL CELLULOSE
dextroamphetamine drug variants containing HYDROXYPROPYL CELLULOSE
dextroamphetamine drug variants not containing HYDROXYPROPYL CELLULOSE
Excipient focus: HYPROMELLOSE
dextroamphetamine drug variants containing HYPROMELLOSE
dextroamphetamine drug variants not containing HYPROMELLOSE
Excipient focus: HYPROMELLOSE 2208
dextroamphetamine drug variants containing HYPROMELLOSE 2208
| Company | Ingredient | NDC |
|---|---|---|
| SpecGx LLC | dextroamphetamine sulfate | 0406-8960 |
| >Company | >Ingredient | >NDC |
dextroamphetamine drug variants not containing HYPROMELLOSE 2208
Excipient focus: HYPROMELLOSE 2910
dextroamphetamine drug variants containing HYPROMELLOSE 2910
dextroamphetamine drug variants not containing HYPROMELLOSE 2910
Excipient focus: HYPROMELLOSES
dextroamphetamine drug variants containing HYPROMELLOSES
dextroamphetamine drug variants not containing HYPROMELLOSES
Excipient focus: ISOPROPYL ALCOHOL
dextroamphetamine drug variants containing ISOPROPYL ALCOHOL
dextroamphetamine drug variants not containing ISOPROPYL ALCOHOL
Excipient focus: LACTOSE MONOHYDRATE
dextroamphetamine drug variants containing LACTOSE MONOHYDRATE
dextroamphetamine drug variants not containing LACTOSE MONOHYDRATE
Excipient focus: MAGNESIUM STEARATE
dextroamphetamine drug variants containing MAGNESIUM STEARATE
dextroamphetamine drug variants not containing MAGNESIUM STEARATE
Excipient focus: MALTODEXTRIN
dextroamphetamine drug variants containing MALTODEXTRIN
dextroamphetamine drug variants not containing MALTODEXTRIN
Excipient focus: MEDIUM-CHAIN TRIGLYCERIDES
dextroamphetamine drug variants containing MEDIUM-CHAIN TRIGLYCERIDES
dextroamphetamine drug variants not containing MEDIUM-CHAIN TRIGLYCERIDES
Excipient focus: METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
dextroamphetamine drug variants containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
dextroamphetamine drug variants not containing METHACRYLIC ACID - ETHYL ACRYLATE COPOLYMER
Excipient focus: METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
dextroamphetamine drug variants containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
dextroamphetamine drug variants not containing METHACRYLIC ACID - METHYL METHACRYLATE COPOLYMER
Excipient focus: METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
dextroamphetamine drug variants containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
dextroamphetamine drug variants not containing METHACRYLIC ACID AND ETHYL ACRYLATE COPOLYMER
Excipient focus: METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER
dextroamphetamine drug variants containing METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals (USA) Inc | dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate and amphetamine sulfate | 70710-1184 |
| >Company | >Ingredient | >NDC |
dextroamphetamine drug variants not containing METHACRYLIC ACID-ETHYL ACRYLATE COPOLYMER
Excipient focus: METHYLCELLULOSE
dextroamphetamine drug variants containing METHYLCELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Physicians Total Care Inc | dextroamphetamine sulfate | 54868-5479 |
| >Company | >Ingredient | >NDC |
dextroamphetamine drug variants not containing METHYLCELLULOSE
Excipient focus: MICROCRYSTALLINE CELLULOSE 101
dextroamphetamine drug variants containing MICROCRYSTALLINE CELLULOSE 101
dextroamphetamine drug variants not containing MICROCRYSTALLINE CELLULOSE 101
Excipient focus: MICROCRYSTALLINE CELLULOSE 102
dextroamphetamine drug variants containing MICROCRYSTALLINE CELLULOSE 102
dextroamphetamine drug variants not containing MICROCRYSTALLINE CELLULOSE 102
Excipient focus: OLEIC ACID
dextroamphetamine drug variants containing OLEIC ACID
dextroamphetamine drug variants not containing OLEIC ACID
Excipient focus: OPADRY YS-1-17274A BEIGE
dextroamphetamine drug variants containing OPADRY YS-1-17274A BEIGE
dextroamphetamine drug variants not containing OPADRY YS-1-17274A BEIGE
Excipient focus: POLY(METHYL ACRYLATE-CO-METHYL METHACRYLATE-CO-METHACRYLIC ACID 7:3:1; 280000 MW)
dextroamphetamine drug variants containing POLY(METHYL ACRYLATE-CO-METHYL METHACRYLATE-CO-METHACRYLIC ACID 7:3:1; 280000 MW)
dextroamphetamine drug variants not containing POLY(METHYL ACRYLATE-CO-METHYL METHACRYLATE-CO-METHACRYLIC ACID 7:3:1; 280000 MW)
Excipient focus: POLYDEXTROSE
dextroamphetamine drug variants containing POLYDEXTROSE
| Company | Ingredient | NDC |
|---|---|---|
| Amneal Pharmaceuticals of New York LLC | dextroamphetamine saccharate, amphetamine aspartate monohydrate, dextroamphetamine sulfate, and amphetamine sulfate | 0115-1486 |
| >Company | >Ingredient | >NDC |
dextroamphetamine drug variants not containing POLYDEXTROSE
Excipient focus: POLYETHYLENE GLYCOL
dextroamphetamine drug variants containing POLYETHYLENE GLYCOL
dextroamphetamine drug variants not containing POLYETHYLENE GLYCOL
Excipient focus: POLYETHYLENE GLYCOL 3350
dextroamphetamine drug variants containing POLYETHYLENE GLYCOL 3350
| Company | Ingredient | NDC |
|---|---|---|
| Strides Pharma Science Limited | dextroamphetamine sulfate | 64380-230 |
| >Company | >Ingredient | >NDC |
dextroamphetamine drug variants not containing POLYETHYLENE GLYCOL 3350
Excipient focus: POLYETHYLENE GLYCOL 400
dextroamphetamine drug variants containing POLYETHYLENE GLYCOL 400
dextroamphetamine drug variants not containing POLYETHYLENE GLYCOL 400
Excipient focus: POLYETHYLENE GLYCOL 8000
dextroamphetamine drug variants containing POLYETHYLENE GLYCOL 8000
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | dextroamphetamine sulfate | 45963-303 |
| >Company | >Ingredient | >NDC |
dextroamphetamine drug variants not containing POLYETHYLENE GLYCOL 8000
Excipient focus: POLYSORBATE 80
dextroamphetamine drug variants containing POLYSORBATE 80
dextroamphetamine drug variants not containing POLYSORBATE 80
Excipient focus: POTASSIUM HYDROXIDE
dextroamphetamine drug variants containing POTASSIUM HYDROXIDE
dextroamphetamine drug variants not containing POTASSIUM HYDROXIDE
Excipient focus: POVIDONE
dextroamphetamine drug variants containing POVIDONE
dextroamphetamine drug variants not containing POVIDONE
Excipient focus: POVIDONE K30
dextroamphetamine drug variants containing POVIDONE K30
| Company | Ingredient | NDC |
|---|---|---|
| Zydus Pharmaceuticals (USA) Inc | dextroamphetamine sulfate | 68382-943 |
| >Company | >Ingredient | >NDC |
dextroamphetamine drug variants not containing POVIDONE K30
Excipient focus: PROPYLENE GLYCOL
dextroamphetamine drug variants containing PROPYLENE GLYCOL
dextroamphetamine drug variants not containing PROPYLENE GLYCOL
Excipient focus: SACCHARIN
dextroamphetamine drug variants containing SACCHARIN
| Company | Ingredient | NDC |
|---|---|---|
| Tris Pharma Inc | dextroamphetamine | 27808-085 |
| Bryant Ranch Prepack | dextroamphetamine | 72162-2043 |
| >Company | >Ingredient | >NDC |
dextroamphetamine drug variants not containing SACCHARIN
Excipient focus: SACCHARIN SODIUM
dextroamphetamine drug variants containing SACCHARIN SODIUM
dextroamphetamine drug variants not containing SACCHARIN SODIUM
Excipient focus: SACCHARIN SODIUM DIHYDRATE
dextroamphetamine drug variants containing SACCHARIN SODIUM DIHYDRATE
dextroamphetamine drug variants not containing SACCHARIN SODIUM DIHYDRATE
Excipient focus: SHELLAC
dextroamphetamine drug variants containing SHELLAC
dextroamphetamine drug variants not containing SHELLAC
Excipient focus: SILICON DIOXIDE
dextroamphetamine drug variants containing SILICON DIOXIDE
dextroamphetamine drug variants not containing SILICON DIOXIDE
Excipient focus: SODIUM CITRATE
dextroamphetamine drug variants containing SODIUM CITRATE
| Company | Ingredient | NDC |
|---|---|---|
| Tris Pharma Inc | dextroamphetamine | 27808-085 |
| Bryant Ranch Prepack | dextroamphetamine | 72162-2043 |
| INDEPENDENCE PHARMACEUTICALS LLC | dextroamphetamine sulfate | 21724-701 |
| Mikart LLC | dextroamphetamine sulfate | 46672-646 |
| Prasco Laboratories | dextroamphetamine sulfate | 66993-359 |
| >Company | >Ingredient | >NDC |
dextroamphetamine drug variants not containing SODIUM CITRATE
Excipient focus: SODIUM HYDROXIDE
dextroamphetamine drug variants containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Strides Pharma Science Limited | dextroamphetamine sulfate | 64380-230 |
| >Company | >Ingredient | >NDC |
dextroamphetamine drug variants not containing SODIUM HYDROXIDE
Excipient focus: SODIUM LAURYL SULFATE
dextroamphetamine drug variants containing SODIUM LAURYL SULFATE
dextroamphetamine drug variants not containing SODIUM LAURYL SULFATE
Excipient focus: SODIUM STARCH GLYCOLATE TYPE A POTATO
dextroamphetamine drug variants containing SODIUM STARCH GLYCOLATE TYPE A POTATO
| Company | Ingredient | NDC |
|---|---|---|
| Tris Pharma Inc | dextroamphetamine sulfate | 27808-089 |
| >Company | >Ingredient | >NDC |
dextroamphetamine drug variants not containing SODIUM STARCH GLYCOLATE TYPE A POTATO
Excipient focus: SODIUM STEARYL FUMARATE
dextroamphetamine drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Lannett Company Inc | dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate | 0527-0760 |
| >Company | >Ingredient | >NDC |
dextroamphetamine drug variants not containing SODIUM STEARYL FUMARATE
Excipient focus: SORBITOL
dextroamphetamine drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Tris Pharma Inc | dextroamphetamine | 27808-085 |
| Bryant Ranch Prepack | dextroamphetamine | 72162-2043 |
| INDEPENDENCE PHARMACEUTICALS LLC | dextroamphetamine sulfate | 21724-701 |
| Mikart LLC | dextroamphetamine sulfate | 46672-646 |
| Prasco Laboratories | dextroamphetamine sulfate | 66993-359 |
| >Company | >Ingredient | >NDC |
dextroamphetamine drug variants not containing SORBITOL
Excipient focus: STARCH, CORN
dextroamphetamine drug variants containing STARCH, CORN
dextroamphetamine drug variants not containing STARCH, CORN
Excipient focus: STARCH, PREGELATINIZED CORN
dextroamphetamine drug variants containing STARCH, PREGELATINIZED CORN
| Company | Ingredient | NDC |
|---|---|---|
| Oryza Pharmaceuticals Inc | dextroamphetamine saccharate, amphetamine aspartate, dextroamphetamine sulfate and amphetamine sulfate | 72516-016 |
| >Company | >Ingredient | >NDC |
dextroamphetamine drug variants not containing STARCH, PREGELATINIZED CORN
Excipient focus: STEARIC ACID
dextroamphetamine drug variants containing STEARIC ACID
dextroamphetamine drug variants not containing STEARIC ACID
Excipient focus: SUCROSE
dextroamphetamine drug variants containing SUCROSE
dextroamphetamine drug variants not containing SUCROSE
Excipient focus: TALC
dextroamphetamine drug variants containing TALC
dextroamphetamine drug variants not containing TALC
Excipient focus: TERT-BUTYL ALCOHOL
dextroamphetamine drug variants containing TERT-BUTYL ALCOHOL
dextroamphetamine drug variants not containing TERT-BUTYL ALCOHOL
Excipient focus: TITANIUM DIOXIDE
dextroamphetamine drug variants containing TITANIUM DIOXIDE
dextroamphetamine drug variants not containing TITANIUM DIOXIDE
Excipient focus: TRIACETIN
dextroamphetamine drug variants containing TRIACETIN
dextroamphetamine drug variants not containing TRIACETIN
Excipient focus: TRIETHYL CITRATE
dextroamphetamine drug variants containing TRIETHYL CITRATE
dextroamphetamine drug variants not containing TRIETHYL CITRATE
Excipient focus: WATER
dextroamphetamine drug variants containing WATER
dextroamphetamine drug variants not containing WATER
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
© Copyright 2002-2024 thinkBiotech LLC
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2024 - 2025
NCE-1 Patent Challenge Dates 2024 - 2025
Trigger-based marketing for the life sciences
Get DrugPatentWatch Business Intelligence Reports at Amazon.com
DrugChatter - AI-based answers to questions about drugs
RxJam - Digital Marketing for Life Sciences
Preferred Citation:
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2024, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch
Links
Follow DrugPatentWatch:
